ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...

Cardiovascular disease is the leading cause of death in the United States, claiming an estimated 1 million lives, and incurring a cost of $400 billion per year. Much of cardiovascular disease can be ...

Once the acquisition is complete, Cardiovascular Systems' devices will join Abbott’s own range of vascular-disease-focused products. That’ll include the company's existing guidewires, catheters and ...

“During Q4, we achieved strong sequential growth across all business segments with our U.S. peripheral and coronary atherectomy franchises growing 9% and 16% over prior quarter, respectively.

For decades, cardiology has been among the most advanced fields in medicine. We have strong evidence, effective medications and clear guidelines for preventing heart attacks and strokes. And yet, ...

Coronary arteries are a vital part of the human heart, providing it with oxygen-rich blood so that it can work. By comparing the hearts of mammals, birds, reptiles, fish and frogs, a ...

Illinois-based medical technology giant Abbott will acquire New Brighton-based medical device company Cardiovascular Systems Inc., the companies announced Wednesday. Under the terms of the agreement, ...

Shares of Cardiovascular Systems (NASDAQ: CSII) are up big today. Specifically, the medical technology company's stock is up by a noteworthy 48.7% as of 10:44 a.m. ET Thursday morning. Cardiovascular ...